Angarus Therapeutics Overview
- Founded
- 2018
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $9.7M
- Investors
- 3
Angarus Therapeutics General Information
Description
Developer of immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The company's therapies develop checkpoint blockers on the innate immunity STING pathway, that enhance the killing power of tumor-infiltrating lymphocytes and produce durable responses in a small fraction of terminal melanoma patients, enabling patients to get access to a wide range of cancer treatments.
Contact Information
Website
www.angarustx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 428 Oakmead Parkway
- Sunnyvale, CA 94085
- United States
+1 (650) 000-0000
Angarus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 22-Jun-2021 | $9.7M | 000.00 | 000.00 | Completed | Pre-Clinical Trials |
| 1. Seed Round | 000 | 000 | 0000 | Completed |
Angarus Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 00.000 | |
| Seed | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Angarus Therapeutics Executive Team (6)
Angarus Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Chih-Ping Liu Ph.D | Angarus Therapeutics | Founder & Chairman | 000 0000 |
| Jean Liu JD | Self | Board Member | 000 0000 |
| Nigel Ray | Angarus Therapeutics | Chief Executive Officer, President & Board Member | 000 0000 |
| Peder Jensen MD | Angarus Therapeutics | Board Member | 000 0000 |
| Peter Langecker Ph.D | Self | Board Member | 000 0000 |
Angarus Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Evolution VC Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Foothill Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Sixth Borough Capital Management | PE/Buyout | Minority | 000 0000 | 000000 0 |